drugset
drugset / Trial / NCT02269228

Tolerability of Asasantin in Healthy Female and Male Subjects

NCT02269228 ↗

Phase 1 Completed 100 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the occurrence of dipyridamole associated headaches in healthy subjects using a titration scheme or not

Timeline

Start
2000-02
Primary completion
2000-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Asasantin ER Unknown — —

Indications

No indication recorded.